Abstracts Archive - Page 560 of 1683 - ATC Abstracts

2019 American Transplant Congress
Cellular And Molecular Characteristics Of Intra-graft Lymphoid Aggregates In Chronic Lung Allograft Dysfunction
E. Miyamoto¹, S. Juvet¹, D. Hwang², S. Keshavjee¹, T. Martinu¹
¹Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada, ²Sunnybrook Health Sciences Centre, Toronto, ON, Canada
*Purpose: Lymphoid aggregates (LAs) have been identified within lung allografts post lung transplant (LTx). However, it remains controversial whether they represent benign lymphoid tissue or…
2019 American Transplant Congress
Treprostinil as a Bridge Therapy to Heart-Lung Transplants with Severe Pulmonary Arterial Hypertension
C. Ju, Q. Lian, B. Wei, X. Xu, J. He, R. Chen
State Key Lab of the Respiratory Disease, Guangzhou Institute of Respiratory Disease, Guangzhou, China
*Purpose: Heart-lung transplants (HLTx) is the only one effective strategy for advanced pulmonary arterial hypertension (PAH) with refractory right heart failure. But limited availability of…
2019 American Transplant Congress
Caregiving before Thoracic Transplantation–A Qualitative Inquiry
C. C. Kennedy¹, J. Ridgeway¹, E. Stevens¹, J. Kirsch², K. Carroll¹, J. Griffin¹, R. Benzo¹
¹Mayo Clinic, Rochester, MN, ²University of Florida-Gainesville, Gainesville, FL
*Purpose: Although post-transplant caregiver (CG) support is a prerequisite for transplant listing, research shows CG outcomes including stress and social functioning may be worse during…
2019 American Transplant Congress
Efficacy and Safety of Alemtuzumab versus Basiliximab Induction in Lung Transplantation
J. Choe, J. Au, A. Diamond, C. Ruggia-Check, S. Sehgal, F. Cordova, N. Shigemura, S. Keshavamurthy, Y. Toyoda
Temple University Hospital, Philadelphia, PA
*Purpose: Minimal literature exists regarding alemtuzumab for induction in lung transplantation but is the preferred agent at Temple University Hospital (TUH). Basiliximab is reserved for…
2019 American Transplant Congress
The Impact Of Early Statin Use Following Lung Transplantation On The Development Of Bronchiolitis Obliterans Syndrome
B. Lindner¹, S. Strout¹, P. Shah²
¹Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, ²Department of Pulmonology, The Johns Hopkins Hospital, Baltimore, MD
*Purpose: Conflicting data exists on the effect of statin therapy on the development of bronchiolitis obliterans syndrome (BOS) following lung transplantation, and limited literature is…
2019 American Transplant Congress
Impact Of Inhaled Vasodilator Therapy On Early Morbidity And Mortality After Lung Transplant
M. Tomeczkowicz¹, A. Wexler¹, M. Patel², J. Fernandez-Castillo², J. Rusniak¹, E. Mancl³, S. Quddus²
¹Department of Pharmacy, Loyola University Medical Center, Maywood, IL, ²Division of Pulmonary and Critical Care, Loyola University Medical Center, Maywood, IL, ³Loyola University Medical Center, Maywood, IL
*Purpose: Within the first 72 hours of lung transplant, recipients may develop primary graft dysfunction (PGD). This complication is associated with acute and chronic rejection,…
2019 American Transplant Congress
Outcomes for Lung Transplantation Recipients with Non-Alcoholic Fatty Liver Disease
A. J. Trindade¹, P. Burkett¹, S. El-Chemaly¹, N. Hashemi², T. Thaniyavarn¹, H. R. Mallidi³, H. J. Goldberg¹
¹Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, ²Gastroenterology and Hepatology, Brigham and Women's Hospital, Boston, MA, ³Division of Thoracic and Cardiovascular Surgery, Brigham and Women's Hospital, Boston, MA
*Purpose: Non-alcoholic Fatty Liver Disease (NAFLD) afflicts ~20-40% people in the western world and is a risk factor for comorbidities prevalent in the lung transplant…
2019 American Transplant Congress
Impact of Size Mismatch on Long-Term Graft Survival after Orthotopic Liver Transplantation
K. Kamrani¹, A. Okoh², A. Mathur³, L. Brown⁴
¹Dept. of Surgery, Monmouth Medical Center, Long Branch, NJ, ²Dept. of Medicine, Newark Beth Israel Medical Center, Newark, NJ, ³Div. of Transplant Surgery, Mayo Clinic, Scottsdale, AZ, ⁴Div. of Liver Transplant Surgery, University Hospital, Newark, NJ
*Purpose: The aim of the current study is to investigate recent trends in mismatched organs utilized for orthotopic liver transplantation (OLT) and examine the impact…
2019 American Transplant Congress
Patient-Reported Self-Management in Lung Transplant Candidates
C. C. Kennedy¹, M. Budev², S. Chandrashekaran³, D. Erasmus⁴, E. D. Lease⁵, D. Levine⁶, K. Thompson¹, E. Stevens¹, R. Benzo¹
¹Mayo Clinic, Rochester, MN, ²Cleveland Clinic, Cleveland, OH, ³University of Florida- Gainesville, Gainesville, FL, ⁴Mayo Clinic, Jacksonville, FL, ⁵University of Washington, Seattle, WA, ⁶University of Texas Health Science Center San Antonio, San Antonio, TX
*Purpose: Pre-transplant risk factors are strongly associated with worse post-transplant survival (e.g. frailty); however, effective pre-transplant strategies to improve outcomes are lacking. We hypothesize that…
2019 American Transplant Congress
Lung Allocation Score Should Be Implemented in China
C. Ju, Q. Lian, B. Wei, X. Xu, R. Chen, J. He
State Key Lab of the Respiratory Disease, Guangzhou Institute of Respiratory Disease, Guangzhou, China
*Purpose: Lung transplantation (LTx) is an effective treatment for patients with end stage of respiratory disease. Two of the major candidates are patients with chronic…